文献速递腹部技术与安全MRUS

二维剪切波弹性成像联合传播图评估慢性肝病患者肝纤维化及临床显著门静脉高压的前瞻性研究

Two-dimensional Shear Wave Elastography with Propagation Maps for the Assessment of Liver Fibrosis and Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Prospective Study.
PubMed 文献 · Acad Radiol · 2019-09-04

前瞻性纳入101例慢性肝病或肝硬化患者,行MR弹性成像(MRE)与二维剪切波弹性成像(SWE),SWE肝硬度值与MRE强相关(r=0.846,P<0.001)。以MRE为参考标准,SWE诊断乙肝相关肝病显著纤维化AUC为0.975、肝硬化AUC为0.912;预测临床显著门静脉高压AUC为0.818,以11.5 kPa为阈值时敏感度81.5%、特异度72.9%。

要点

  • 二维SWE肝硬度值与MRE肝硬度值强相关(r=0.846,P<0.001),可用于无创评估肝纤维化。
  • 乙肝相关肝病患者中,SWE诊断显著纤维化(MRE≥2.99 kPa)AUC为0.975,诊断肝硬化(MRE≥3.63 kPa)AUC为0.912。
  • 预测临床显著门静脉高压AUC为0.818,肝硬度11.5 kPa为阈值时敏感度81.5%、特异度72.9%。

核心结论

  • 二维SWE肝硬度测量与MRE测量值相关性良好,对肝纤维化及临床显著门静脉高压的预测可能具有良好诊断效能。

研究设计与样本

  • 前瞻性研究,纳入101例慢性肝病或肝硬化患者,均行MRE与SWE检查;排除MRE技术失败5例、SWE技术失败或测量不可靠4例;以MRE肝硬度值为参考标准,采用Pearson相关及ROC曲线分析。

关键影像表现/征象

  • SWE肝硬度值与MRE肝硬度值呈强相关(r=0.846,P<0.001)。

诊断标准与关键数值

  • 显著纤维化定义为MRE≥2.99 kPa(≥F2);肝硬化定义为MRE≥3.63 kPa(F4)。
  • 预测临床显著门静脉高压,SWE的AUC为0.818(95%CI 0.712-0.898);以肝硬度11.5 kPa为阈值时,敏感度81.5%、特异度72.9%。

临床应用与阅片要点

  • 二维SWE肝硬度测量可辅助无创评估肝纤维化分期及临床显著门静脉高压风险。
  • 以MRE为参考标准时,SWE对乙肝相关肝病显著纤维化和肝硬化的诊断AUC分别为0.975和0.912。
  • 预测临床显著门静脉高压时,肝硬度11.5 kPa阈值对应敏感度81.5%、特异度72.9%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the diagnostic performance of liver stiffness (LS) measurements on two-dimensional (2D) shear wave elastography (SWE) for the assessment of hepatic fibrosis using LS measurements on MR elastography (MRE) as the reference standard and the prediction of clinically significant portal hypertension (CSPH).

METHODS: In this prospective study, 101 patients with chronic liver disease or cirrhosis underwent both MRE and SWE. After exclusion of technical failure on MRE (n = 5), technical failure/unreliable measurement on SWE (n = 4), LS measurements obtained on SWE with the aid of propagation maps were correlated with those of the MRE using Pearson's correlation analysis. Diagnostic performances for significant fibrosis (≥F2: MRE of ≥2.99 kPa) or cirrhosis (F4: MRE of ≥3.63 kPa) and for the prediction of CSPH were assessed using receiver operating characteristics (ROC) curve analysis.

RESULTS: LS values on SWE showed a strong correlation with those on MRE (r = 0.846, P < 0.001). For the diagnosis of significant fibrosis or cirrhosis in patients with hepatitis B virus-related liver disease (n = 75), SWE showed areas under the ROC curves (AUC) of 0.975 and 0.912, respectively (95% confidence interval [CI], 0.910-997, and 0.824-0.965). For the prediction of CSPH, the AUC of SWE was 0.818 (95% CI, 0.712-0.898), and when an LS value of 11.5 kPa was applied as a cut-off, SWE showed a sensitivity of 81.5% and a specificity of 72.9%.

CONCLUSION: LS measurements on 2D SWE were demonstrated to be well correlated with those obtained with MRE, and thus, may provide good diagnostic performance for the prediction of hepatic fibrosis and the presence of CSPH.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Jeon SK, Lee JM, Joo I, et al. Two-dimensional Shear Wave Elastography with Propagation Maps for the Assessment of Liver Fibrosis and Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Prospective Study. Acad Radiol. 2019. PMID: 31494001. doi:10.1016/j.acra.2019.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。